Solvay SA

DB:SOL

Belgium / Bahan / Kimia

Tinjauan

Dividen

Kewangan Sejarah 5T

Harga Saham

32.26 EUR


Key Metrics	Latest
Total Revenue	5.13 B
Adjusted EBITDA	919 M
EBITDA Margin	17.9%
Net Profit Margin	7.8%
Total Assets	6.694 B
Total Debt	2.138 B

5Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	12 Months	Dec-23	Dec-24

Revenue	9,714.00	11,434.00	7,979.00	6,024.00	5,130.00	5,130.00	6,024.00	5,130.00
% Growth		0.18	(0.30)	(0.25)	(0.15)			(0.15)

Adjusted EBITDA	1,716.00	1,946.00	1,898.00	1,523.00	919.00	919.00	1,523.00	919.00
% Margin	0.18	0.17	0.24	0.25	0.18	0.18	0.25	0.18

Adjusted EBIT	861.00	1,211.00	1,124.00	793.00	602.00	602.00	793.00	602.00
% Margin	0.09	0.11	0.14	0.13	0.12	0.12	0.13	0.12

Adjusted Net Income	235.76	1,122.20	2,041.84	2,540.82	402.46	402.46	2,540.82	402.46
% Margin	0.02	0.10	0.26	0.42	0.08	0.08	0.42	0.08

Adjusted Basic EPS	2.29	10.84	19.68	24.39	3.83	3.83	24.39	3.83

Menyokong Pengiraan

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
						Press Release
EUR	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	Dec-24	Dec-23	Dec-24
	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM	YTD-1	YTD

Revenue	9,714	11,434	7,979	6,024	5,130	5,130	6,024	5,130
% Growth	NA	17.7%	-30.2%	-24.5%	-14.8%			-14.8%

Cost of Revenue	(7,207)	(8,508)	(6,554)	(4,642)	(3,984)	(3,984)	(4,642)	(3,984)
Gross Profit	2,507	2,926	1,425	1,382	1,146	1,146	1,382	1,146
% Revenue	25.8%	25.6%	17.9%	22.9%	22.3%	22.3%	22.9%	22.3%

Research and Development	(327)	(352)	(46)	(47)	(34)	(34)	(47)	(34)
Selling and Marketing	(312)	(287)	(94)	(100)	(93)	(93)	(100)	(93)
General and Admin	(900)	(946)	(471)	(452)	(326)	(326)	(452)	(326)
Other Inc / (Exp)	(1,708)	(157)	344	(574)	(282)	(282)	(574)	(282)
Total Operating Exp	(3,247)	(1,742)	(267)	(1,173)	(735)	(735)	(1,173)	(735)

Operating Income	(740)	1,184	1,158	209	411	411	209	411
% Revenue	-7.6%	10.4%	14.5%	3.5%	8.0%	8.0%	3.5%	8.0%

Interest Expense	(104)	(90)	(27)	(29)	(91)	(91)	(29)	(91)
Pre-tax Income	(844)	1,094	1,131	180	320	320	180	320
Earnings of Discontinued Ops.	163	5	1,016	2,130	0	0	2,130	0
Provision for Taxes	(248)	(110)	(228)	(208)	(87)	(87)	(208)	(87)
Net Income to Company	(929)	989	1,919	2,102	233	233	2,102	233
% Margin	-9.6%	8.6%	24.1%	34.9%	4.5%	4.5%	34.9%	4.5%

Minority Interest in Earnings	(33)	(41)	(14)	(9)	(10)	(10)	(9)	(10)
Net Income to Stockholders	(962)	948	1,905	2,093	223	223	2,093	223

Preferred Dividends	0	0	0	0	0	0	0	0
Other Adj.	(163)	(5)	(1,016)	(2,130)	0	0	(2,130)	0

Net Income to Common	(1,125)	943	889	(37)	223	223	(37)	223
% Margin	-11.6%	8.2%	11.1%	-0.6%	4.3%	4.3%	-0.6%	4.3%

As Reported
Basic EPS (Continuing Ops)	(10.91)	9.11	8.57	(0.36)	2.12	2.12	(0.36)	2.12
Diluted EPS (Continuing Ops)	(10.91)	9.09	8.54	(0.36)	2.10	2.10	(0.36)	2.10

WA Basic Shares Out.	103.14	103.53	103.74	104.16	105.00	105.00	104.16	105.00
WA Diluted Shares Out.	103.14	103.79	104.14	104.16	106.05	106.05	104.16	106.05

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	(844)	1,094	1,131	180	320	320	180	320
Addback: Net Interest Expense	104	90	27	29	91	91	29	91
Addback: Other Non Operating Expenses, Total	27	(153)	(200)	(9)	(38)	(38)	(9)	(38)
Addback: Depreciation & Amortization	855	735	774	730	317	317	730	317
Addback: Restructuring Charges	122	181	13	51	89	89	51	89
Addback: Merger / Acquisition Expenses	25	47	83	404	0	0	404	0
Addback: Goodwill Impairment	1,050	0	0	38	0	0	38	0
Addback: Gain (Loss) On Sale Of Invest.	8	(9)	0	(4)	22	22	(4)	22
Addback: Gain (Loss) On Sale Of Assets	(3)	(12)	(3)	(3)	0	0	(3)	0
Addback: Asset Writedown	351	0	(37)	57	45	45	57	45
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0
Addback: Legal Settlements	20	(61)	0	0	0	0	0	0
Addback: Other Unusual Items	1	34	110	50	73	73	50	73
Adjusted EBITDA	1,716	1,946	1,898	1,523	919	919	1,523	919
% Margin	17.7%	17.0%	23.8%	25.3%	17.9%	17.9%	25.3%	17.9%

Adjusted EBIT	861	1,211	1,124	793	602	602	793	602
% Margin	8.9%	10.6%	14.1%	13.2%	11.7%	11.7%	13.2%	11.7%

Adjusted Net Income Reconciliation
Net Income to Company	(929)	989	1,919	2,102	233	233	2,102	233
Addback: Unusual Items	1,574	180	166	593	229	229	593	229
Less: Tax Benefit of Unusual Items (26%)	(409)	(47)	(43)	(154)	(60)	(60)	(154)	(60)
Adjusted Net Income	236	1,122	2,042	2,541	402	402	2,541	402
% Margin	2.4%	9.8%	25.6%	42.2%	7.8%	7.8%	42.2%	7.8%

Hak cipta terpelihara. Terma Penggunaan

Ralat Memuat Turun

Solvay SA

DB:SOL

Belgium / Bahan / Kimia

Kewangan Sejarah 5T